GlobeNewswire Inc.··DelveinsightBiosimulation Market to Hit $20B by 2034 as Drug Developers Embrace Virtual Trials
Global biosimulation market projected to expand from $4.7B in 2025 to $20B by 2034 at 17% CAGR, driven by regulatory support and virtual trial adoption.
DASTYSLPCERTSDGRdrug developmentprecision medicine